New Zealand Secures Monkeypox Medicine, But Finds it Difficult to Get Vaccine Supply

Test tubes labeled "Monkeypox virus positive" are seen in this illustration taken on May 23, 2022. Dado Ruvic/Illustration/Reuters

The New Zealand government has announced it has secured a supply of tecovirimat, the medicine used to treat monkeypox, but was still working to secure a supply of the monkeypox vaccine, known as Jynneos or Imvanex.

Associate Minister of Health Ayesha Verrall said that 504 courses of tecovirimat are expected to be available in the country from late September.